Perbedaan Archi Indonesia Tbk dan Cipta Sarana Medika Tbk.: Archi Indonesia Tbk diperdagangkan di Rp1.210 (kapitalisasi pasar 31,42 T, volume 24 jam 13,33 jt), sedangkan Cipta Sarana Medika Tbk. diperdagangkan di Rp65 (kapitalisasi pasar 160,67 M, volume 24 jam 12,27 jt). Perbedaan utamanya: Archi Indonesia Tbk jauh lebih besar — sekitar 195,6× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Archi Indonesia Tbk lebih aktif diperdagangkan (13,33 jt vs 12,27 jt). Mana yang lebih baik tergantung tujuan investasimu.
| ARCI | DKHH | |
|---|---|---|
Kapitalisasi Pasar | 31,42 T | 160,67 M |
Volume | 13,33 jt | 12,27 jt |
Lot | 133,35 rb | 122,69 rb |
Perputaran | 16,29 M | 785,75 jt |
Harga Rata-rata | 1.221,57 | 64,04 |
Nilai Transaksi | 16,29 M | 785,75 jt |
Harga Ekuilibrium Indikatif | 1.255 | 63 |
Volume Ekuilibrium Indikatif | 1,47 rb | 4,8 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Selengkapnya di halaman ARCI →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →